A previous study reported that half of a group of 14 NKTCL-N cases possessed a mutation in the Fas gene, suggesting that Fas gene mutation is the pathological basis of NKTCL and that its mechanism of action involves the inhibition of the apoptosis of lymphocytes (19). Here, FAS is linked to extranodal nasal NK/T cell lymphoma.